Adapting your practice: treatment and recommendations for unstably housed patients with HIV/AIDS.

  • Guideline Summary
  • NGC:009278
  • 2004 May (revised 2012)

Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia.

  • Guideline Summary
  • NGC:010502
  • 2014 Jun

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotype.

  • Guideline Summary
  • NGC:010331
  • 2014 Feb

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and PEG interferon-α–based regimens.

  • Guideline Summary
  • NGC:010769
  • 2015 Jul

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing.

  • Guideline Summary
  • NGC:009210
  • 2003 Feb (revised 2012 Aug)

Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.

  • Guideline Summary
  • NGC:009736
  • 2007 Jun (revised 2013 Apr)

NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer.

  • Guideline Summary
  • NGC:011073
  • 2016 Jan

Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections: a Laboratory Medicine Best Practices systematic review and meta-analysis.

  • Guideline Summary
  • NGC:010358
  • 2013 Mar 1

The clinical utility of sperm DNA integrity testing: a guideline.

  • Guideline Summary
  • NGC:010000
  • 2011 May (revised 2013 Aug)

Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).

  • Guideline Summary
  • NGC:010006
  • 2011 Aug (revised 2013 Sep)

Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.

  • Guideline Summary
  • NGC:010329
  • 2012 Feb (revised 2014 Apr)

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.

  • Guideline Summary
  • NGC:006287
  • 1999 Sep (revised 2008 Jan; reaffirmed 2012)

Elective and risk-reducing salpingo-oophorectomy.

  • Guideline Summary
  • NGC:010066
  • 1999 Aug (revised 2013 Aug)

2013 UK national guideline for the management of lymphogranuloma venereum.

  • Guideline Summary
  • NGC:010007
  • 2013 Sep

Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing.

  • Guideline Summary
  • NGC:010330
  • 2013 Dec

Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing.

  • Guideline Summary
  • NGC:010590
  • 2012 Jul (revised 2014 Oct)

The Clinical Pharmacogenetics Implementation Consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.

  • Guideline Summary
  • NGC:010396
  • 2002 May-Jun (revised 2014 Apr)

American College of Medical Genetics and Genomics guideline for the clinical evaluation and etiologic diagnosis of hearing loss.